Almirall, S.A. (ALMRY)

Market Cap	2.89B
Revenue (ttm)	1.24B
Net Income (ttm)	25.06M
Shares Out	n/a
EPS (ttm)	0.12
PE Ratio	115.38
Forward PE	33.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	202
Open	12.76
Previous Close	11.51
Day's Range	12.76 - 12.76
52-Week Range	9.23 - 12.76
Beta	0.39
RSI	78.45
Earnings Date	Nov 10, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALMRY

Financial Performance

Financial numbers in EUR